tradingkey.logo
tradingkey.logo
Suchen

Integra Lifesciences Holdings Corp

IART
Zur Watchlist hinzufügen
18.050USD
+0.160+0.89%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
1.41BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Integra Lifesciences Holdings Corp Unternehmen

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Integra Lifesciences Holdings Corp Informationen

BörsenkürzelIART
Name des UnternehmensIntegra Lifesciences Holdings Corp
IPO-datumAug 16, 1995
CEOPoul (Mojdeh)
Anzahl der mitarbeiter4396
WertpapierartOrdinary Share
GeschäftsjahresendeAug 16
Addresse1100 Campus Road
StadtPRINCETON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl08540
Telefon16092750500
Websitehttps://www.integralife.com/
BörsenkürzelIART
IPO-datumAug 16, 1995
CEOPoul (Mojdeh)

Führungskräfte von Integra Lifesciences Holdings Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Mojdeh Poul
Ms. Mojdeh Poul
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
102.30K
--
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
--
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
88.25K
-1.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
50.49K
-16.02%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
35.42K
+38.07%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
34.65K
-3.31%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Integra Lifesciences Holdings Corp?

Die fünf größten Anteilseigner von Integra Lifesciences Holdings Corp sind: Ms. Mojdeh Poul

Wie viele Institutionen halten Anteile an Integra Lifesciences Holdings Corp (IART)?

Mit Stand vom 2026Q1 halten 574 Institutionen Anteile an Integra Lifesciences Holdings Corp, mit einem Gesamtmarktwert von etwa 82.80M, was 106.43% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -14508057.00 gestiegen.

Was ist die größte Einnahmequelle von Integra Lifesciences Holdings Corp?

Am 2026Q1 erzielte das Geschäft mit Neurosurgery für Integra Lifesciences Holdings Corp den höchsten Umsatz in Höhe von 827.67M, was 50.61% des Gesamtumsatzes entspricht.